Merit Medical Systems | MMSI - Cash And Equivalent

Stock Price
61.36
Daily Change
-1.20 -1.92%
Monthly
-12.47%
Yearly
-37.91%
Q2 Forecast
60.13

Merit Medical Systems reported $488.08M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
3M USD 3.73B 1.51B Mar/2026
Abbott USD 6.8B 1.72B Mar/2026
AngioDynamics USD 41.64M 14.26M Sep/2025
Anika Therapeutics USD 41.02M 16.46M Mar/2026
AtriCure USD 146.16M 21.26M Mar/2026
Baxter International USD 2.02B 51M Mar/2026
Becton, Dickinson and Co. USD 813M 73M Mar/2026
Boston Scientific USD 1.45B 512M Mar/2026
Cooper Companies USD 110.6M 14.3M Sep/2025
Dexcom USD 1.12B 200.5M Mar/2026
Edwards Lifesciences USD 2.4B 538M Mar/2026
Globus Medical USD 560.95M 34.79M Mar/2026
Haemonetics USD 363.37M 66.94M Dec/2025
ICU Medical USD 307.96M 8.23M Dec/2025
Insulet USD 480.4M 235.7M Mar/2026
Integra LifeSciences USD 236.81M 1.76M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Merit Medical Systems USD 488.08M 41.68M Mar/2026
Olympus JPY 147.24B 93.98B Sep/2025
Pfizer USD 1.7B 561M Mar/2026
STAAR Surgical USD 153.15M 23M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 179.32M 88.69M Mar/2026
Teleflex USD 309.41M 69.15M Mar/2026
Terumo JPY 217.16B 12.86B Sep/2025
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026